Bank Of America Corp Chinook Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.66 - $38.58 $124,424 - $257,251	-6,668 Reduced 2.12%	308,007 $11.8 Million
Q1 2023 May 12, 2023	BUY	$21.53 - $26.8 $3.01 Million - $3.74 Million	139,652 Added 79.79%	314,675 $7.28 Million
Q4 2022 Feb 10, 2023	BUY	$18.63 - $27.35 $669,003 - $982,138	35,910 Added 25.81%	175,023 $4.59 Million
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $959,880 - $1.28 Million	54,819 Added 65.03%	139,113 $2.74 Million
Q2 2022 Aug 12, 2022	BUY	$12.59 - $18.8 $228,772 - $341,614	18,171 Added 27.48%	84,294 $1.47 Million
Q1 2022 May 16, 2022	SELL	$12.02 - $16.69 $1.82 Million - $2.53 Million	-151,662 Reduced 69.64%	66,123 $1.08 Million
Q4 2021 Feb 08, 2022	BUY	$10.69 - $16.83 $14,677 - $23,107	1,373 Added 0.63%	217,785 $3.55 Million
Q3 2021 Nov 15, 2021	SELL	$11.5 - $14.86 $667 - $861	-58 Reduced 0.03%	216,412 $2.76 Million
Q2 2021 Sep 13, 2021	BUY	$13.6 - $18.98 $2.94 Million - $4.11 Million	216,470 New	216,470 $3.06 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.